Trial Profile
Observational Study of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Menactra Administered in Individuals 2 Through 55 Years Old Under Standard Health Care Practice in the Russian Federation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2019
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 13 Oct 2016 Status changed from recruiting to completed.
- 10 Mar 2016 New trial record